Quid des produits de contraste en TEP/TDM ?
- 1 April 2007
- journal article
- Published by Elsevier in Médecine Nucléaire
- Vol. 31 (4) , 202-205
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive PatientsJournal of Clinical Oncology, 2006
- Positron emission tomography/computed tomography improves diagnostics of inflammatory arteritisHeart and Vessels, 2005
- PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Non-Hodgkin Lymphoma and Hodgkin Disease: Coregistered FDG PET and CT at Staging and Restaging—Do We Need Contrast-enhanced CT?Radiology, 2004
- Dual-Modality PET/CT Scanning with Negative Oral Contrast Agent to Avoid Artifacts: Introduction and EvaluationRadiology, 2004